Home
Conditions
Sezary Syndrome

Clinical trial condition

Sezary Syndrome

Explore clinical trials studying Sezary Syndrome. Study availability and eligibility vary by location and protocol.

262 public trials 17 recruiting studies

Refine in advanced search Browse all conditions

Sezary Syndrome trial results

Completed

PET Study in Patients With Non-Hodgkin Lymphoma

NCT00712556

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +36 more
Locations: Vanderbilt-Ingram Cancer Center - Cool Springs Nashville, Tennessee, United States

Vanderbilt-Ingram Cancer Center at Franklin Nashville, Tennessee, United States

Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States

View Trial Details

Completed

Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer

NCT00823524

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +101 more
Locations: University of Ulsan, Asan Medical Center Seoul, South Korea

View Trial Details

Completed

Panobinostat and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma

NCT00962507

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +49 more
Locations: City of Hope Medical Center Duarte, California, United States

City of Hope Medical Group Pasadena, California, United States

View Trial Details

Completed

BMS-247550 in Treating Patients With Advanced Cancers

NCT00006221

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +43 more
Locations: Cancer Therapy and Research Center San Antonio, Texas, United States

Veterans Affairs Medical Center - San Antonio (Murphy) San Antonio, Texas, United States

University of Texas Health Science Center at San Antonio San Antonio, Texas, United States

View Trial Details

Completed

Rebeccamycin Analog and Cisplatin With or Without Filgrastim in Treating Patients With Advanced Cancer

NCT00004189

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +43 more
Locations: University of Texas Health Science Center at San Antonio San Antonio, Texas, United States

Cancer Therapy and Research Center San Antonio, Texas, United States

St. Luke's Lutheran Hospital San Antonio, Texas, United States

View Trial Details

Completed

17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma

NCT00004241

Conditions: AIDS-related Peripheral/Systemic Lymphoma, AIDS-related Primary CNS Lymphoma, Anaplastic Large Cell Lymphoma, +105 more
Locations: University of Pittsburgh Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction

NCT00025415

Conditions: AIDS-related Peripheral/Systemic Lymphoma, AIDS-related Primary CNS Lymphoma, Accelerated Phase Chronic Myelogenous Leukemia, +170 more
Locations: University of Pittsburgh Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

Irinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or Lymphoma

NCT00002759

Conditions: Agranulocytosis, Burkitt Lymphoma, Chemically-Induced Disorders, +51 more
Locations: University of Chicago Cancer Research Center Chicago, Illinois, United States

View Trial Details

Completed

Photodynamic Therapy in Treating Patients With Lymphoma or Chronic Lymphocytic Leukemia

NCT00054171

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +19 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

17-DMAG in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphomas

NCT00089271

Conditions: Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Blood Protein Disorders, +97 more
Locations: University of Pittsburgh Pittsburgh, Pennsylvania, United States

View Trial Details

Sezary Syndrome

Sezary Syndrome trial results

Related conditions